Qinghai Chenfei Pharmaceutical First Market Approval for Exenatide Biosimilar Supported by UP-Pharma
发布时间 : 2022-08-19
点击 : 0
16 UPP Warriors Stayed at The Post During The 2-month Shanghai COVID lockdown
- Categories:News & Events
- Author:
- Origin:
- Time of issue:2022-06-24 17:04
- Views:
(Summary description)
16 UPP Warriors Stayed at The Post During The 2-month Shanghai COVID lockdown
(Summary description)
- Categories:News & Events
- Author:
- Origin:
- Time of issue:2022-06-24 17:04
- Views:
Information
The latest COVID-19 outbreak in Shanghai led to many disturbances to our daily lives and regular company operation. A specific and detailed contingency plan has been executed at UP-Pharma to ultimately ensure effective disease prevention and minimize the impact on project delivery. During the most challenging time, numbers of employees voluntarily stayed on duty to ensure the continuous project support.
UPP arranged necessary food and supply delivery to each employee in Shanghai.
Scan the QR code to read on your phone
Contact Us
Beijing Address：Tower B, No.33 Science Park Road, Changping District, Beijing, P. R. China 102206
Shanghai Address：Building 30, Lane 908, Ziping Road, Pudong New Area, Shanghai, P. R. China 201318
Tianjin Address：Building B03, Venture Headquarters, Fuyuan Road North, Wuqing Development Zone, Tianjin, P. R. China 301700
Guangxi Address：Building 3, Yunlang Science Park, Fangcheng District, Fangchenggang City, Guangxi,P. R. China 838000
Business Email：BD@up-pharma.com
Recruitment Email：hr@up-pharma.com
Copyright © 2022 United-Power Pharma Tech Co., Ltd (UPP) All Rights Reserved 京ICP备15042399号
